News

Researchers were able to coax layers of cells to form shapes not found in nature, such as cubes.

A pioneering public/private consortium is poised to turn the marathon of drug discovery into a team relay, maybe even a short one.

Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products through bioengineering; Regulatory science leadership; Tobacco burden in vulnerable populations; Economics of disease; Precision medicine. Education: Preparing leaders who think critically, work across fields, and lead in rapidly changing marketplaces. PharmD curriculum for 2018 and beyond; Transforming teaching; Coursework in regulatory science and translational medicine; Interdisciplinary exposure. Patient Care: Reframing how medication needs of patients are met. Importance of health information exchange; Outcomes research; Treating patients with more precise medications. People: Supporting our agents of change—our faculty, staff, and alumni. New faculty leaders; Housing and child care; Staff support and engagement; PharmD admissions; Unconscious bias. Framework for Success: Ensuring the School has the framework needed to excel. Support for enabling technology centers; Philanthropic support; Online presence.

Ching C. Wang, PhD, a beloved UCSF School of Pharmacy researcher and professor, known for bringing molecular biology and biochemistry to parasitology, and for his work on the antiparasitic medicine ivermectin, died last week at the age of 80. To his wide circle of colleagues and friends, he was known simply as “C.C.”